Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Finasteride treatment changes hormone levels in male pattern baldness patients.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Testosterone increases hamster hair growth; cyproterone acetate reduces it.

Combining terbinafine and mitotane effectively treated a schnauzer's skin infection and hormone disorder.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New compounds may soon be tested to treat excessive hair growth in women.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.